Diabetes

08/30/2012 - 10:28am
NextGen, Nipro Diagnostics create telemedicine capability monitoring diabetes patients

NextGen Healthcare Information Systems on Wednesday announced a telemedicine agreement with Nipro Diagnostics that would enable users of the company's NextGen Ambulatory EHR instant access to data points captured by patients at home who are using the Nipro TrueResult blood-glucose monitoring system.

08/16/2012 - 1:45pm
HealthPartners, VitalSims partner to create chronic disease education programs

A nonprofit healthcare education organization and a for-profit company that uses healthcare education technology to promote best practices in medicine are developing educational programs to improve chronic disease care.

08/15/2012 - 12:03pm
Watson sues FDA over generic Actos

Watson Pharmaceuticals is suing the Food and Drug Administration, alleging that an agency decision would improperly delay its release of a generic drug for diabetes, the company said Wednesday.

08/03/2012 - 9:40am
Philosys seeks FDA approval for blood-glucose meter

Philosys is seeking regulatory approval from the Food and Drug Administration for its blood-glucose monitoring system.

07/31/2012 - 11:41am
Onglyza improves blood-sugar control in patients with high cardiovascular disease risk

A drug made by Bristol-Myers Squibb and AstraZeneca improved several measures of blood-sugar control in Type 2 diabetes patients at high risk of cardiovascular disease, according to results of a late-stage clinical trial announced Monday.

07/30/2012 - 10:16am
Takeda resubmits diabetes drug applications

Drug maker Takeda Pharmaceutical has resubmitted regulatory approval applications for two drugs designed to treat diabetes, the company said.

07/24/2012 - 1:16pm
Walmart expands ReliOn brand, announces price reduction for items

Walmart has launched an effort to help diabetes patients save on their disease management products.

07/23/2012 - 12:02pm
Study: Long-term use of linagliptin among Type 2 diabetics is effective

Extended use of the oral DPP-4 inhibitor linagliptin to lower blood-glucose levels by Type 2 diabetes patients is effective, according to a new study.

07/18/2012 - 11:50am
Diabetic test strip counterfeiter pleads guilty

Jacques Duplessis on Monday pleaded guilty to engaging in a scheme to sell approximately 6,000 boxes of counterfeit LifeScan One Touch diabetic test strips that he purchased from suppliers in China and England, announced U.S. attorney Zane David Memeger.

07/16/2012 - 11:09am
GlaxoSmithKline to acquire Human Genome Sciences for $3.6 billion

British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.

© 2013 Drug Store News. All Rights Reserved.